For the past 40 years, ITC has been a world leader in the fields of hemostasis management and point-of-care testing.

Our exclusive focus is to measure more at the point-of-care than anyone else. Our activity in the scientific community and dedication to superior support provide technical service and training that's second to none.

So we're there for you, wherever you need us.

And that's exactly the point-of-care.

  • Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission

    PLEASANTON, Calif., FRAMINGHAM, Mass. and SYDNEY, Australia, March 26 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts,

    Read more
  • Thoratec Presentation at Raymond James Conference to Be Webcast

    PLEASANTON, Calif., March 3 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it will be participating in...

    Read more
  • Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million;

    Combined Company Will Offer Broad Portfolio Of Devices To Improve Therapies For Heart Failure Patients PLEASANTON, Calif., FRAMINGHAM, Mass., SYDNEY, Feb. 13 /PRNewswire- FirstCall/ -- Thoratec Corporation (Nasdaq: THOR),

    Read more
Breaking News